secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001477932-25-002897
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx enters up to $7.5M at-the-market stock offering agreement with JonesTrading
--------------------------------------------------------------------------------

- New 'Capital on Demand' sales agreement with JonesTrading allows sale of up to $7.5M common stock via ATM.
- Sales agent commission 3% of gross proceeds; company not obligated to sell any shares.
- Replaces prior $25M ATM program with Jefferies, terminated effective April 20, 2025.
- Proceeds intended for R&D, product development, clinical studies, commercialization, working capital, and potential acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793225002897/0001477932-25-002897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793225002897/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-002897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer